Literature DB >> 15924501

The precautionary principle and pharmaceutical risk management.

Torbjörn Callréus1.   

Abstract

Although it is often vigorously contested and has several different formulations, the precautionary principle has in recent decades guided environmental policy making in the face of scientific uncertainty. Originating from a criticism of traditional risk assessment, the key element of the precautionary principle is the justification for acting in the face of uncertain knowledge about risks. In the light of its growing invocation in various areas that are related to public health and recently in relation to drug safety issues, this article presents an introductory review of the main elements of the precautionary principle and some arguments conveyed by its advocates and opponents. A comparison of the characteristics of pharmaceutical risk management and environmental policy making (i.e. the setting within which the precautionary principle evolved), indicates that several important differences exist. If believed to be of relevance, in order to avoid arbitrary and unpredictable decision making, both the interpretation and possible application of the precautionary principle need to be adapted to the conditions of pharmaceutical risk management.

Mesh:

Year:  2005        PMID: 15924501     DOI: 10.2165/00002018-200528060-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  21 in total

1.  Precautionary principle stifles discovery.

Authors:  S Holm; J Harris
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

2.  Risk management. Science and the precautionary principle.

Authors:  K R Foster; P Vecchia; M H Repacholi
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

Review 3.  Reenergizing public health through precaution.

Authors:  D Kriebel; J Tickner
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

Review 4.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Pondering the precautionary principle.

Authors:  Marie-Christophe Boissier
Journal:  Joint Bone Spine       Date:  2003-09       Impact factor: 4.929

6.  Risk assessment of drugs, biologics and therapeutic devices: present and future issues.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-12       Impact factor: 2.890

7.  Precautionary principle encourages policies that protect human health and the environment in the face of uncertain risks.

Authors:  Joel A Tickner
Journal:  Public Health Rep       Date:  2002 Nov-Dec       Impact factor: 2.792

8.  The precautionary principle within European Union public health policy. The implementation of the principle under conditions of supranationality and citizenship.

Authors:  Lila Antonopoulou; Philip van Meurs
Journal:  Health Policy       Date:  2003-11       Impact factor: 2.980

9.  Benefit-risk analysis: a proposal using quantitative methods.

Authors:  William L Holden; Juhaeri Juhaeri; Wanju Dai
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Oct-Nov       Impact factor: 2.890

Review 10.  Principles of signal detection in pharmacovigilance.

Authors:  R H Meyboom; A C Egberts; I R Edwards; Y A Hekster; F H de Koning; F W Gribnau
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

View more
  3 in total

1.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

2.  Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.

Authors:  Daniel M Cook; Rama K Gurugubelli; Lisa A Bero
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification.

Authors:  Igho J Onakpoya; Carl J Heneghan; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.